Evaluating tacrolimus treatment in idiopathic membranous nephropathy in a cohort of 408 patients

Abstract

Low dose tacrolimus is effective for IMN, with a total remission rate of 66% whereas with a rather high rate of relapse. However, the safety of tacrolimus treatment needs to be further validated in large randomized clinical trials.